Carregant...

Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells

Our results show that using an EBV-LCL feeder cell line, large numbers of pure populations of highly activated NK cells can be expanded ex vivo under GMP conditions. With the exception of thyroiditis and constitutional symptoms related to IL-2 therapy, infusions of up to 1 x 10(8) cells/kg of ex viv...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lundqvist, Andreas, Berg, Maria, Smith, Aleah, Childs, Richard W.
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3133963/
https://ncbi.nlm.nih.gov/pubmed/21750690
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!